The enzyme xanthine: acceptor oxidoreductase found in rat heart equilibrates between three forms differing in electron acceptor specificity. Form D transfers electrons exclusively to NAD + and accounts for 85% of total oxidoreductase activity. Form O transfers electrons to molecular oxygen and accounts for 8%. The D/O form prefers NAD + , but without NAD + transfers electrons to oxygen. Interconversion from D to O and O to D forms is catalyzed by sulfhydryl group-modifying reagents: Cd 2+ , Cu 2+ , disulfiram, and heating with dithiothreitol. This suggests that sulfhydryl groups participate in the first stage of enzyme conversion. The NADH/NAD + concentration ratio may regulate the dehydrogenase activity of xanthine:acceptor oxidoreductase (NAD + -dependent activity of D and D/O forms). Accumulating NADH inhibits hypoxanthine hydroxylation. The amount of form O increases during cardiac ischemia, facilitating superoxide radical-ion generation. Also, NADH/NAD + does not regulate form O, promoting adenylate nucleotide pool depletion, especially in the heart which has low de novo purine nucleotide synthesis. (Circulation Research 1986;59:628-632) 
I N recent years, there has been much interest in the biochemical mechanisms of cardiac tissue injury. 1 Schoutsen et al 2 and Chambers et al 3 found a NAD + -dependent xanthine oxidoreductase in rat heart. However, this enzyme has not been well characterized. Xanthine: acceptor oxidoreductase catalyzes two consecutive hydroxylations: hypoxanthine to xanthine, and xanthine to uric acid, the end product of human purine catabolism. There are two well-known classes of oxidoreductases. The first uses molecular oxygen as an electron acceptor; the second uses NAD + . Xanthine: oxygen oxidoreductase (trivial name xanthine oxidase; current E.C. 1.1.3.22) has been extensively investigated in the last 80 years. 4 The NAD + -dependent enzyme (xanthine: NAD + oxidoreductase; trivial name xanthine dehydrogenase; current E.C. 1.1.1.204) was discovered more recently 56 because this enzyme is less stable, especially in mammalian tissues.
NAD + -dependent xanthine oxidoreductase is the form found in vivo. 6 "" Rat liver xanthine: acceptor oxidoreductase equilibrates between three forms: D, D/O, and O, which differ in their electron acceptor specificity. The D form is primary and uses NAD + exclusively as the electron acceptor. The D/O form transfers electrons to oxygen in the absence of NAD + but prefers NAD + as an electron acceptor. Form 0 does not occur in fresh liver enzyme preparations but appears during storage. Form O uses molecular oxy-gen as the preferred electron acceptor. Form O can transfer to other electron acceptors such as methylene blue, but oxygen is preferred in physiological conditions." During storage, form D spontaneously converts to form D/O and then to form O. The reverse conversion occurs when the enzyme is heated with dithiothreitol or cysteine, reagents which reduce disulfide bridges. 12 Little is known about the properties of nonliver xanthine oxidoreductase. Heart tissue is especially important because cardiac purine and purine nucleotide metabolism are important in cardiac ischemia. 13 This paper characterizes xanthine: acceptor oxidoreductase from rat heart.
Materials and Methods

Animals
Adult male Sprague-Dawley rats (250-300 g), housed in groups of six in a ventilated rodent facility at 20-25° C, were on a 0700-1900 light and 1900-0700 dark cycle. Standard rat chow 5012 (Ralston Purina) and water were given ad libitum. Rats were decapitated between 0900 and 1100 and the hearts removed immediately.
Reagents
Hypoxanthine (6-hydroxypurine), xanthine (2,6dihydroxypurine), phenyl-methylsulfonyl fluoride (PMSF), dithiothreitol (DTT), 4-(2-hydroxyethyl)piperazinepropanesulfonic acid (HEPPS), [2-(hydroxy-1, l-bis(hydroxymefhylethyl]-amino-1 -propanesulfonic acid (TAPS), diethylenetriaminepentaacetic acid (DTPA), ethylenediaminetetraacetic acid (EDTA), beef liver L-lactate dehydrogenase (LDH; 1000 U/ml), /3-nicotinamide adenine dinucleotide (NAD + ) grade V and Sephadex G-25 fine were purchased from the Sigma Chemical Co., St. Louis, Mo. Special enzyme grade ammonium sulfate and density gradient grade sucrose were purchased from Schwartz/ Mann, Orangeburg, N.Y. Disulfiram (tetraethylthioperoxydicarbonic diamide) was prepared and purified as described previously. 14 
Enzyme Preparation
Each rat heart was immediately homogenized in a chilled razor blade homogenizer for three alternative periods of 15 seconds on and 15 seconds off. The homogenization buffer contained 50 mM HEPPS/ KOH (pH 8.0), 200 mM sucrose, and 10 mM DTT. In some experiments, 0.1 mM PMSF was added to the homogenization buffer, or the tissue was immediately frozen in liquid nitrogen. In some experiments, DTT was excluded. The homogenate was centrifuged at 30,000 g for 30 minutes and the supernatant removed. The supernatant was ultracentrifuged at 160,000 g for 60 minutes. The resulting supernatant was fractioned with 3.8 M ammonium sulfate according to Wood. 15 The fraction precipitating in the range of 1.4-2.4 M ammonium sulfate contained all of the oxidoreductase activity. This fraction was resuspended in 250 mM sucrose (1 ml/g of heart tissue) and kept at -80° C. This partially purified enzyme had an activity six times that of the crude (30,000 g) supernatant.
Spectrophotometric Assays
All assays used a Cary 219 or UVICON 810 recording spectrophotometer with repetitive scan. This allowed consecutive absorption determinations at two or three wavelengths. Quartz cells, 1-cm path length, 3 ml, were used. All determinations were made at 25° C.
Xanthine Hydroxylation Assays
The standard incubation mixture contained 50 mM HEPPS/KOH buffer, pH 8.0, and an enzyme preparation (3-11 mg of total protein determined by the Goa 16 modified biuret method) with or without 500 /xm NAD + . Some samples contained 40 nkat LDH and 0.5 mM sodium pyruvate, to provide instant NADH reoxidation. The blank contained no xanthine." Xanthine oxidoreductase activity was measured by monitoring the formation of uric acid at 302 nm and NADH at 340 nm. When LDH and pyruvate were present, no NADH was formed.
The amounts and percents of D, D/O, and O forms were calculated as described previously." Enzymatic activities are in katals (1 kat = 1 mol product/sec), or percent of total oxidoreductase activity.
Xanthine: Acceptor Oxidoreductase Modification by CcP + or Cu 2+ Ions
Enzyme preparations were preincubated for 5 minutes with CdSO 4 (20-250 /xM), or CuSO 4 (40^50 jLtM). The reactions were stopped by adding 100 mM DTPA/KOH, pH 8.0, to a final DTPA concentration of 500
Modification by DTT of Xanthine: Acceptor Oxidoreductase Activity
The enzyme (0.1 ml, 130 pkat/ml) was prepared without DTT and PMSF in the homogenization buffer.
The enzyme was characterized before and after incubation with 20 mM DTT at 45° C for 25 minutes. After incubation, the enzyme was cooled on ice for 5 minutes and passed through a Sephadex G-25 column equilibrated with 20 mM TAPS/KOH buffer, pH 8.0. The enzyme solution was shown to be DTT free by a negative test with Ellman's reagent (after protein precipitation).
Michaelis Constant Determination for Xanthine
The K M of xanthine was determined from a reaction curve using 16 /xM initial xanthine concentration and a saturating NAD + concentration (500 /J.M). The absorption at 302 nm was monitored to complete xanthine exhaustion. The reaction was carried out under aerobic conditions with LDH and pyruvate. The partial velocities and substrate concentrations were calculated from the integrated Michaelis-Menten equation according to Waley. 17 The K M was estimated using the computer algorithm of Cornish-Bowden et al. 18 
Studies on the Time-course of Hypoxanthine Hydroxylation
Hypoxanthine hydroxylation was studied in the presence of accumulating NADH or with instantaneous NADH reoxidation by LDH and pyruvate. Absorption at 279, 302, and 340 nm was continuously recorded. 19 -20 TAPS/KOH buffer (950 mM), pH 8.0, replaced HEPPS to avoid interference at 279 nm.
Results
The total activity of xanthine: acceptor oxidoreductase in rat heart (as determined with a saturating xanthine concentration of 150 /J L M and a NADH reoxidizing system) is 460 pkat/g of fresh tissue, or 77 ± 3 nkat/g of total protein in a partially purified preparation. The total activity of the crude preparation (supernatant after 30,000 g) was 13 ± 2 nkat/g total protein.
The Michaelis constant for xanthine was 2.42 jiiM, with confidence limits of 1.95 to 2.87, 18 the same value as for rat liver oxidoreductase. 2 ' Uric acid is a weak xanthine oxidoreductase inhibitor with a K, = 1.6 mM. 22 In this experiment, the maximum concentration of uric acid during the xanthine K M determination was 16 IJLM. Even at high concentrations (40 £iM), the plots of log concentration of hypoxanthine disappearance vs. time fit a straight line with a correlation coefficient of 0.996. Since these lines do not curve with increasing uric acid concentration, we assume that the amount of uric acid formed during the experiment did not inhibit the enzyme.
In contrast to the liver enzyme," all three forms of xanthine: acceptor oxidoreductase are found in fresh heart preparations. Cardiac oxidoreductase activity typically contained 85% form D, 7% form D/O, and 8% form O. Several attempts were made to block form O appearance. To this end, the homogenization buffer was modified by the addition of PMSF (0.1 mM) or EDTA (0.25 mM). This did not increase or decrease the appearance of form O.
Form D was completely converted to form O by Results are expressed as mean ± SE. treatment with 60 fiM Cd 2+ or 200 yM CU 2+ . Disulfiram, which modifies sulfhydryl groups in a highly specific manner, 14 also increased oxygen-dependent activity. Table 1 summarizes these results. Table 2 summarizes the results of the experiment in which DTT was absent in the preparation buffer. Preparations were assayed for total activity and the relative abundance of each form was calculated. The preparations were then incubated with 20 mM DTT at 45° C for 25 minutes and assayed again. There was a marked decrease in the relative abundance in form O while the amount of form D/O changed little. The total activity remained unchanged.
The dehydrogenase activity of xanthine: acceptor oxidoreductase (mainly form D) was inhibited by NADH accumulation. Typical data for hypoxanthine, xanthine, and uric acid with and without the regeneration of NAD + from NADH are shown in Figure 1 . The hypoxanthine data were fit to a multiexponential model for kinetic analysis using the Biomedical Data Processing Program BMDP-P3R (BMDP Statistical Software, Inc., Los Angeles, Calif.), available to the public on the Michigan Terminal System. The best fit for the hypoxanthine data with and without NAD + regeneration was a two parameter model of the form HX(t) = Ae at . The best fit data are given in Table 3 . The percent inhibition with NADH present was calculated as percent differences in rates (a). The disappearance of hypoxanthine, most significant to our discussion, was inhibited 48% in the presence of NADH. The percent inhibition did not increase with increasing NADH concentrations. It has previously been shown that enzyme forms D and D/O are inhibited by NADH in rat liver preparations." 19
Discussion
Heart xanthine: acceptor oxidoreductase is important both as a free radical source and in purine nucleotide catabolism. For many years, biochemists believed xanthine oxidase had only one form and transferred electrons only to oxygen. This incorrect point of view is still deeply rooted in the current literature. Stirpe and Delia Corte 7 discovered the enzyme actually to be xanthine: NAD + oxidoreductase. During storage or preparation without sulfhydryl group-protecting agents, the enzyme lost NAD + -dependent activity and gained oxygen dependence. Stirpe and Delia Corte distinguished three forms of xanthine: acceptor oxidoreductase: Type O uses oxygen as an electron acceptor; type D uses only NAD + and is the in vivo form; an "intermediate" form uses both acceptors. The crude enzyme preparation used by Stirpe and Delia Corte did not allow the D/O form to be found. Further purification was needed to quantify the activities of the different forms. Crude enzyme preparations contain excess protein which interferes with the spectrophotometric assays, especially at 279 nm. Additionally, a correction for NADVNADH absorption during uric acid determination at 292 nm was not used in the original Stirpe and Delia Corte procedure (see spectra in Bergmeyer 23 ). This correction was included in this study, according to Kaminski and Jezewska." The accuracy of the method used has been shown on grass snake liver, which has only NAD + -dependent activity. 20 The enzyme preparation used had a specific activity of 77 nkat/g protein, 6 times greater than the crude supernatant. This allowed absorption at 302, 340, and 279 nm to be monitored. In rat heart, all three forms of the enzyme are interconvertible. Cardiac enzyme preparations with 10 mM DTT contained 7% form O, 8% form D/O, and 85% form D. These proportions did not change in the presence of a protease inhibitor (PMSF) or a reagent chelating heavy metal ions (EDTA). Moreover, the presence or absence of DTT played a significant role in the relative abundance of form O without changing the total enzyme activity.
Chambers et al 3 suggested that proteolysis causes the appearance of oxidase activity. Our results show the NAD + -dependent activity in heart oxidoreductase preparations disappeared during treatment with the sulfhydryl modifying reagents Cd 2+ , Cu 2+ , and disulfiram. Proteolysis may be a further conversion step, 26 " 28 The extreme inhibitory potency 29 and specificity of allopurinol for mammalian xanthine: acceptor oxidoreductase suggests that the inhibition of all forms, especially form O of xanthine oxidase (E.C. 1.1.3.22) may play an important role in the reperfusion injury process. 3 Hypoxanthine hydroxylation followed the same pattern for NADH dependence as the liver enzyme. l9 This suggests another consequence of D to O conversion, that is, the increased depletion of the cardiac adenylate nucleotide pool (see Mauser et al 30 for an extensive discussion). Hypoxanthine is the last substrate in purine catabolism salvageable for purine nucleotide synthesis. It should be noted that myocardium has poor de novo purine nucleotide synthesis. 30 Consequently, hypoxanthine loss depletes AMP levels; ATP production falls even with elevated phosphocreatine. This may decrease the Atkinson energetic potential and contribute to myocardial ischemic damage. We found most of the enzyme in the D and D/O forms, both strongly inhibited by NADH, unlike form O. NADH accumulates during ischemia, but the oxidase activity increases. 3 Form O escapes inhibition due to an increasing NADH/NAD + ratio and may deplete the adenylate nucleotide pool. The physiological and clinical significance of this is as yet unknown. The ratio between D + D/O (total dehydrogenase activity at physiological conditions) and O after myocardial ischemia needs to be determined.
